CLASS II ONGOING Drug recall · Reported 4 Nov 2026 · FDA Enforcement Report

Lidocaine Ointment USP, 5.0 % recalled by Direct Rx

Direct Rx is recalling Lidocaine Ointment USP, 5.0 %, distributed nationwide in the US. The recall was initiated on 29 Sep 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.
Quantity recalled493 jars

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0107-2027
FDA event ID
100229
Recalling firm
Direct Rx, Dawsonville, GA
Classification
Class II
Status
Ongoing
Recall initiated
29 Sep 2026
FDA classified
29 Oct 2026
Reported
4 Nov 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay
Drug class
Pain Medication

Timeline

29 Sep 2026Recall initiated by company
29 Oct 2026Classified by FDA+30 days
4 Nov 2026Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Subpotent Drug

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50

Where it was distributed

Nationwide within the United States

Nationwide

Questions about this recall

Why was it recalled?

Subpotent Drug

Which lots are affected?

LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.

Where was it sold?

Nationwide within the United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 10 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Direct Rx

All 38

Other Lidocaine recalls

All 120